-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
The Future of the Cardiac Intensive Care Unit
David Dudzinski, MD, director of the Heart Center Intensive Care Unit, discusses how his team combines the specialties of cardiology intensive care, cardiac anesthesia and cardiac surgery into a unified care team model to take care of the entire span of patients of acute, critical, cardiovascular illness.
-
#AHA18: Scientific Sessions in Summary
Mass General physicians answer the question: "What was the most interesting topic presented at this year's Scientific Sessions?"
-
#AHA18 on Twitter: New Cholesterol Guidelines, the PIONEER-HF Trial and More
Health care professionals at this year’s American Heart Association's Scientific Sessions discussed late-breaking research, innovative treatment approaches and brand new guidelines. The conversations carried over from the podium and conference halls onto Twitter.
-
Endothelin-1 Is a Prognostic Marker in Patients Undergoing Coronary Angiography
By measuring endothelin-1 via a blood test, cardiologists may someday be able to determine which patients with cardiovascular disease are at highest risk of heart failure, myocardial infarction and death.
Learn more about Mass General's Heart Failure and Cardiac Transplant Program
Heart Failure contributors
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
#AHA18 on Twitter: New Cholesterol Guidelines, the PIONEER-HF Trial and More
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
